Loading…
CIK 0001274403 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("arch-venture-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 10X GENOMICS INC | CL A COM | $4.6M | 0.7% | 217,834 SH | New |
| BEAM THERAPEUTICS INC | COM | $108.2M | 16.0% | 4,540,132 SH | New |
| ERASCA INC | COM | $114.7M | 16.9% | 7,091,557 SH | New |
| GENERATE BIOMEDICINES INC | COM SHS | $24.3M | 3.6% | 1,944,426 SH | New |
| GOSSAMER BIO INC | COM | $2.6M | 0.4% | 8,055,916 SH | New |
| LYELL IMMUNOPHARMA INC | COM NEW | $65.1M | 9.6% | 3,247,162 SH | New |
| MAZE THERAPEUTICS INC | COM | $123.0M | 18.2% | 4,120,053 SH | New |
| Q32 BIO INC | COM | $2.1M | 0.3% | 320,482 SH | New |
| RAPPORT THERAPEUTICS INC | COM | $116.7M | 17.2% | 3,728,738 SH | New |
| VIR BIOTECHNOLOGY INC | COM | $115.7M | 17.1% | 12,916,663 SH | New |
| 13F-HR |
| 0001012975-26-000794 |
| $1.10B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001012975-25-000444 | $299.1M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001012975-26-000461 | $677.1M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001012975-25-000245 | $206.2M | View |